Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Jane Andre Rogerson
Introduction
Jane Andre Rogerson is a notable inventor based in St. Albans, GB. She has made significant contributions to the field of medicine, particularly in the treatment of infectious diseases. Her work has the potential to impact the lives of many individuals suffering from chronic infections.
Latest Patents
Rogerson holds a patent for the use of IL-12 and IFN.alpha. for the treatment of infectious diseases. This invention provides a combination of IL-12 and IFN.alpha. along with a pharmaceutically acceptable carrier, which is useful for both treatment and prophylaxis of infectious diseases. The patent specifically addresses chronic infectious diseases, including viral infections such as HSV, HIV, Hepatitis B, and Hepatitis C, as well as bacterial infections like tuberculosis and salmonellosis, and parasitic infections such as malaria and leishmaniasis. The compositions are characterized by the synergistic interaction of IL-12 and IFN.alpha., showcasing the innovative approach Rogerson has taken in her research.
Career Highlights
Jane Andre Rogerson is currently associated with Hoffmann-La Roche Inc., where she continues to advance her research and development efforts. Her work has garnered attention in the scientific community, and she is recognized for her contributions to the field of infectious disease treatment.
Collaborations
Rogerson has collaborated with esteemed colleagues such as Gottfried Alber and Jacqueline Anne Carr. These partnerships have further enriched her research and have contributed to the success of her innovative projects.
Conclusion
Jane Andre Rogerson's work exemplifies the spirit of innovation in the medical field. Her patent for the use of IL-12 and IFN.alpha. represents a significant advancement in the treatment of infectious diseases. Through her career and collaborations, she continues to make a lasting impact on healthcare.